Search

Your search keyword '"Schwartz, Marc"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Schwartz, Marc" Remove constraint Author: "Schwartz, Marc" Journal american journal of gastroenterology Remove constraint Journal: american journal of gastroenterology
45 results on '"Schwartz, Marc"'

Search Results

4. S0810 Dual Biologic Therapy for the Treatment of Severe/Refractory Inflammatory Bowel Disease: Intravenous Immunoglobulin in Combination With Standard Biologic Agents

5. S0809 Is There a Benefit of Immunomodulator and Anti-TNF Combination Therapy Over Monotherapy in the Real World, Long-Term Management of IBD? Assessing Multiyear Treatment Persistence and Mucosal Healing

6. S0890 Can IBD Medications Counteract the Negative Effects of a Deleterious, High Sugar Diet?

7. S0651 Type of Surgical Anastomosis Influences Long-Term Clinical Status, Quality of Life, and Opioid Requirement in Post-Operative Crohn's Disease: A 3-Year Comparative Effectiveness Study

8. S0808 The Biomarker Peripheral Blood Eosinophilia Predicts Failure to Achieve Mucosal Healing in Inflammatory Bowel Disease

11. 741 Low Serum Levels of IgG4 Antibodies May Function as a Biomarker of Severity in Inflammatory Bowel Disease

12. 745 Developing Precision Medicine in IBD: Peripheral Blood Eosinophilia Identifies Individuals With Worse Outcomes Following Initiation of Anti-TNF Biologic Agents

13. Can We Develop Precision Medicine for Biologic Selection in IBD Based on Routinely Available Clinical Information? Using Big Data Analytics to Identify Predictors of Anti-TNF Response

15. Ileocecal Anastomosis Type Significantly Influences Long-Term Functional Status, Quality of Life, and Healthcare Utilization in Postoperative Crohn's Disease Patients Independent of Inflammation Recurrence

16. Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype

17. Low Dietary Fiber Intake in Inflammatory Bowel Disease Is Associated with Active Disease and Poor Quality of Life: 2016 ACG Presidential Poster Award

18. Patterns Between Multi-Year Steroid Use in Patients with Inflammatory Bowel Disease and Quality of Life, Disease Severity, and Healthcare Utilization

19. Variation in Annual Rate of Steroid Prescriptions Among Providers for Inflammatory Bowel Disease Patients Is Dependent on Disease Severity

20. Peripheral Blood Eosinophilia as a Potential Marker of Bowel Damage Progression in Crohnʼs Disease a 5 Year Natural History Study

21. Comparative Effectiveness of Common Immunomodulator Agents over 5 Year Clinical Outcomes in Crohnʼs Disease Patients

23. Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study

24. Quality of Life After Permanent Ileostomy in IBD Patients: A 5-year Prospective Cohort

25. Correlation of Cumulative Diagnostic Radiation Exposure With Increasing Lemann Index: The Need for Increased Provider Vigilance in Certain Crohnʼs Disease Sub-groups

28. Patterns of Clostridium difficile Testing and Infection in Crohnʼs Disease Patients Stratified by Lémann Score Trajectories: A Five-Year Prospective Study

29. Vitamin D Status Is an Independent Risk Factor for Colonic Dysplasia in IBD: A Case-Control Study

30. Stratification of Crohn’s Disease Patients Using the Lemann Index to Quantify Gut Damage: A 5-Year Prospective Study: ACG Governors Award for Excellence in Clinical Research Presidential Poster

34. Does End-to-End vs Side-to-Side Anastomosis in Postoperative Crohn’s Disease Matter? Prospective 2-Year Evaluation of Postoperative Quality of Life, Health Care Utilization, and Clinical Activity

37. Deep Vein Thrombosis in Geriatric IBD Admissions

39. Aspirin Use in Geriatric Crohnʼs Disease

43. Marital Status, Gender and Geriatric Crohnʼs Disease

Catalog

Books, media, physical & digital resources